Antiarrhythmic agents – after a paradigm shift

ISSN： 2195-2175

Source： PHARMAKON, Vol.1, Iss.4, 2013-07, pp. : 307-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anti-arrhythmic agents

By Trybulski E.J.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 5, 1997-05 ,pp. : 457-469

Informa Healthcare

Access to resources Recommend Favorite

The Shift in the “Paradigm” of the Pharmacology of Hypertension

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 4, 2004-02 ,pp. : 487-498

Bentham Science Publishers

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Class III Antiarrhythmic Agents

By Brendorp B.

Drug Safety, Vol. 25, Iss. 12, 2002-01 ,pp. : 847-865

Adis International

Access to resources Recommend Favorite

A benefit–risk assessment of class III antiarrhythmic agents

By Elming Hanne Brendorp Bente Pehrson Steen Pedersen Ole Dyg Køber Lars Torp-Petersen Christian

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 559-577

Informa Healthcare

Access to resources Recommend Favorite

New antiarrhythmic agents for atrial fibrillation and atrial flutter

By Pecini Redi Elming Hanne Pedersen Ole Dyg Torp-Pedersen Christian

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 311-322

Informa Healthcare

Access to resources Recommend Favorite